Tenaya Therapeutics Inc. is a publicly traded enterprise listed on the NASDAQ stock exchange under the ticker symbol TNYA, meaning its ownership is distributed among institutional mutual funds, venture capital firms, corporate insiders, and public retail investors. Institutional asset management firms hold the majority of the corporate equity, steering its overarching clinical and administrative governance.